Search
Search Results
-
The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b–N3c Disease Who Receive Adjuvant Radiotherapy
BackgroundFor breast cancer with advanced regional lymph node involvement, axillary lymph node dissection (ALND) remains the standard of care for...
-
CEM immediately after contrast-enhanced CT: a one-step staging of breast cancer
BackgroundContrast-enhanced mammography (CEM) is a promising technique. We evaluated the diagnostic potential of CEM performed immediately after...
-
Superparamagnetic iron oxide (SPIO) for axillary map** in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience
PurposeUnnecessary axillary surgery can potentially be avoided in patients with DCIS undergoing mastectomy. Current guidelines recommend upfront...
-
Predictive Factors for Unnecessary Axillary Dissection According to SLN Metastasis in T1, T2 Stage Breast Cancer
The axillary nodes’ status is essential in determining the treatment algorithm according to complete clinical staging. Unnecessary axillary lymph...
-
Supraclavicular and Contralateral Axillary Lymph Node Involvement in Breast Cancer Patients
Ipsilateral supraclavicular disease was reclassified from Stage IV, distant metastatic disease, to Stage IIIC, locally advanced breast cancer 20...
-
Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey
PurposeUK NICE guidelines recommend axillary node clearance (ANC) should be performed in all patients with biopsy-proven node-positive breast cancer...
-
Survival After Contralateral Axillary Metastasis in Breast Cancer
BackgroundDespite stage IV categorization, survival outcomes for breast cancer patients who experience contralateral axillary lymph node metastasis...
-
Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?
PurposeTo assess the accuracy of preoperative sonographic staging for prediction of limited axillary disease (LAD, one or two metastatic lymph nodes)...
-
Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging
PurposeBreast cancer diagnosis often involves assessing the locoregional spread of the disease through MRI, as multicentricity, multifocality and/or...
-
Axillary Reverse Map** Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population
BackgroundBreast cancer-related lymphedema (BCRL) poses a significant risk following sentinel lymph node biopsy (SLNB) and axillary lymph node...
-
Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes
BackgroundFine needle aspiration (FNA) of sonographically suspicious axillary lymph nodes is helpful to clinically stage patients and guide...
-
Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer
BackgroundRobotic surgical systems enable surgeons to perform precise movement in the surgical field using high-resolution 3D vision and flexible...
-
Association of Breast Cancer Subtypes and Clinicopathological Factors with Axillary Lymph Node Positivity Amongst Women with Breast Cancer in Rajasthan: An Observational Analytical Study
Prognostic factors by definition, are capable of providing information on clinical outcomes at the time of diagnosis, independent of therapy. The...
-
Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study
BackgroundTargeted axillary sampling (TAS) is a new surgical concept for the assessment of axillary lymph node status in breast cancer that is...
-
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol
PurposeIn clinically node-positive (cN+) breast cancer patients, evidence supporting response-guided treatment after neoadjuvant systemic therapy...
-
Use of imaging prediction model for omission of axillary surgery in early-stage breast cancer patients
PurposeTo develop a prediction model incorporating clinicopathological information, US, and MRI to diagnose axillary lymph node (LN) metastasis with...
-
Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging?
PurposePreoperative evaluation of clinical N-stage (cN) is difficult in breast cancer patients with invasive lobular carcinoma (ILC). Our goal was to...
-
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer
PurposeWhile 18 F-FDG PET/CT (FDG-PET/CT) is consensual for clinical stage ≥ IIB breast cancers (BC), its benefit for stage I or IIA HER2+ or...
-
Axillary Recurrence in Sentinel Lymph Node-Negative Breast Cancer Patients in a Tertiary Referral Cancer Centre
Sentinel lymph node biopsy is the standard of care for axillary staging in clinically node-negative breast cancer. SLNB is predictive of axillary...